The multichain interleukin 2 receptor. A target for immunotherapy in lymphoma, autoimmune disorders, and organ allografts [clinical reference].
Waldmann
T A
TA
Metabolism Branch, National Cancer Institute, Bethesda, MD 20892.
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000628:therapy*; D006084:Graft Rejection / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000628:therapy*; D008297:Male; D015375:Receptors, Interleukin-2
D000911:Antibodies, Monoclonal; D015375:Receptors, Interleukin-2